Hemostasis and Thrombosis Center News and Updates

1 - 10 of 23

Gene Therapy for Hemophilia: Are We There Yet?

Published on

Recent gene therapy trial for hemophilia B showed promising results, with patients’ average factor IX level of 32 percent after treatment. CHOP aims to open a hemophilia A gene therapy trial modeled after the hemophilia B trial.

Behind-the-scenes Leader: Mary Louise Mattia

Published on

Mary Louise Mattia helps make the Hemostasis and Thrombosis Center (HTC) run! She is the HTC program coordinator and data coordinator, and is the voice you hear when you call the HTC office.

Calendar Created to Support Hemophilia Program at CHOP

Published on

One of our HTC families created a fundraising project to support hemophilia research through the CHOP Foundation. The response has been so terrific that Zoe, the sister of our patient “Iron Max,” has upped the fundraising goal multiple times.

Transition Resources for Your Family

Published on

CHOP's Transition to Adulthood Program website has a Resources section that includes age-specific tip sheets for parents or guardians and for children and youth, videos and information about in-person workshops that are hosted for families and teens.

Patient Experience Survey Coming to Clinic

Published on

As part of our ongoing goal to provide the best care possible and to collect required data, all patients between the ages of 12 and 22 will be asked to complete a patient experience survey when you come to clinic for your annual comprehensive care visit.